Amryt Pharma (AMYT) Cash Flow Annual - Discounting Cash Flows
Amryt Pharma plc
AMYT (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
03-31
2014
03-31
2013
03-31
2012
03-31
2011
03-31
2010
03-31
2009
03-31
2008
03-31
2007
12-31
Report Filing: 2022-04-29 2021-04-30 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-03-31 2014-03-31 2013-03-31 2012-03-31 2011-03-31 2010-03-31 2009-03-31 2008-03-31 2007-12-31
Net Income/Starting Line
-18.2 -105 -65.5 -29.5 -31.4 -8.21 -39.9 -2.93 -3.51 -0.28 -0.28 -0.28 -0.46 -3.28 -2.43
Cash From Operating Activities
15.5 26.9 -37.5 -14.9 -14.2 -6.43 -3.80 -2.07 -1.08 -0.40 -0.29 -0.26 -0.39 -3.01 -1.95
Depreciation and Amortization
50.7 44.5 12.7 0.35 0.31 0.20 0.01 0.01 0.00 0.00 0.10 0.15 0.14 0.22 0.16
Deferred Income Tax
-13.4 -0.54 -1.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Stock Based Compensation
8.34 4.73 0.84 0.79 0.68 0.24 0.13 0.46 0.39 0.00 0.00 0.00 0.00 0.00 0.00
Other Non-Cash Items
-4.19 87.2 28.1 12.0 14.3 1.15 36.6 0.00 1.23 -0.06 -0.10 -0.15 -0.07 -0.04 0.01
Changes in Working Capital
-7.84 -4.39 -11.9 1.39 1.82 0.19 -0.59 0.40 0.81 -0.06 0.00 0.03 0.00 0.08 0.30
Accounts Receivable
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory
-13.3 -10.6 -5.89 -0.90 -0.38 -0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Revenue
5.45 6.22 -5.99 2.29 2.20 0.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Working Capital
0.00 0.00 0.00 0.00 0.00 0.00 -0.59 0.40 0.81 -0.06 0.00 0.03 0.00 0.08 0.30
Cash From Investing Activities
106 -2.38 24.4 -0.24 -0.38 2.59 3.15 -27.2 -4.13 0.63 0.29 0.11 0.01 -0.78 -1.06
Investments in Property Plant and Equipment
-1.54 -2.47 -0.65 -0.23 -0.40 -0.01 -17.4 -0.01 -0.02 0.00 0.00 -0.01 0.00 -0.77 -0.76
Payments for Acquisitions
108 0.00 25.0 0.00 0.00 -10.0 0.00 0.00 -0.92 0.00 0.00 0.00 0.00 -0.06 0.00
Purchases of Securities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Sales and Maturities of Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Investing Activities
0.00 0.09 0.09 -0.01 0.02 12.6 3.15 -27.2 -3.19 0.63 0.29 0.11 0.01 0.05 -0.31
Cash From Financing Activities
-125 26.0 65.9 3.18 29.2 12.4 0.00 15.0 34.7 0.00 0.00 -0.13 0.67 3.64 3.23
Debt Repayment
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common Stock Issued
4.70 37.9 63.0 0.00 17.3 11.8 0.00 15.0 35.7 0.00 0.00 0.00 0.43 3.16 2.71
Common Stock Repurchased
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividends Paid
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Financing Activities
-125 26.0 65.9 3.18 29.2 12.4 0.00 0.00 34.7 0.00 0.00 -0.13 0.67 0.67 3.64
Effect of Forex Changes on Cash
-2.27 1.03 3.13 -0.23 0.09 0.00 0.00 0.18 1.07 0.00 0.00 0.00 0.00 0.00 0.00
Net Change in Cash
-5.77 51.6 56.0 -12.2 -1.58 8.52 -0.64 -14.1 30.5 0.24 0.00 -0.23 0.29 -0.16 0.22
Cash at Beginning of Period
119 67.2 11.2 23.5 9.92 0.18 17.4 31.5 0.98 0.00 0.00 0.27 -0.03 0.12 1.00
Cash at End of Period
113 119 67.2 11.2 8.35 8.70 16.8 17.4 31.5 0.24 0.00 0.04 0.26 -0.04 1.22
Free Cash Flow
14.0 24.4 -38.1 -15.2 -14.6 -6.44 -21.2 -2.08 -1.09 -0.40 -0.29 -0.26 -0.39 -3.78 -2.71
Operating Cash Flow
15.5 26.9 -37.5 -14.9 -14.2 -6.43 -3.80 -2.07 -1.08 -0.40 -0.29 -0.26 -0.39 -3.01 -1.95
Capital Expenditure
-1.54 -2.47 -0.65 -0.23 -0.40 -0.01 -17.4 -0.01 -0.02 0.00 0.00 -0.01 0.00 -0.77 -0.76
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us